Valo
biological discovery opal human based capabilities designed to enable discovery of targets linked to precisely selected patient populations get | Valo
Company
Deck Type
Deck date
June 2021
Slide
18 of 35
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical well understood clinical safety with a drug like profile further confidence prior studies suggestive of potential therapeutic benefit | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical flexible patient selection strategy and study design disease overview mutant cancers | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical patient population large diagnosable and easy to identify large unmet need with significant cost burden disease overview difficile infection | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical patient population large and diagnosable no approved medical therapy disease overview cerebral cavernous malformations | Recursion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io